Nasdaq-listed genetics and diagnostic health testing firm Prenetics has formed a $200-million joint venture named Insighta with a renowned molecular biologist, making it the largest private life-sciences deal in the history of Hong Kong as well as in Asia this year.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
